公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 GRIFOLS BRASIL LTDA取消

154 记录

产品持有公司班级有效性
ID CORE XT Reagents80134860219GRIFOLS BRASIL LTDAIV04/07/2036
PROCLEIX ULTRIO ELITE Assay80134860220GRIFOLS BRASIL LTDAIV04/07/2036
Anti-K (Cellano) Mono-Type80134860243GRIFOLS BRASIL LTDAIV10/07/2027
Anti-Fya Mono-Type80134860244GRIFOLS BRASIL LTDAIV10/07/2027
Anti-H Mono-Type80134860245GRIFOLS BRASIL LTDAIV10/07/2027
Anti-D IgG Mono-Type80134860246GRIFOLS BRASIL LTDAIV10/07/2027
Anti-Jka for DG Gel e Anti-Jkb for DG Gel80134860247GRIFOLS BRASIL LTDAIV10/07/2027
Anti-Fya for DG Gel e Anti-Fyb for DG Gel80134860249GRIFOLS BRASIL LTDAIV10/07/2027
Anti-K Mono-Type (2)80134860251GRIFOLS BRASIL LTDAIV26/02/2028
DG Gel ABO/Rh (2D)(RT)80134860259GRIFOLS BRASIL LTDAIV13/12/2028
Família Anti-Kpa Dual e Anti-Kpb Dual80134860261GRIFOLS BRASIL LTDAIV03/06/2029
Procleix Zika Vírus80134860266GRIFOLS BRASIL LTDAIV30/09/2029
Reverse-Cyte 0.8%80134860269GRIFOLS BRASIL LTDAIV25/11/2029
Família Reverse-Cyte® 5%80134860273GRIFOLS BRASIL LTDAIV28/12/2030
Procleix Plasmodium Assay80134860289GRIFOLS BRASIL LTDAIV05/06/2033
Anti-Fyb Mono-Type Dual80134860292GRIFOLS BRASIL LTDAIV26/06/2033
Procleix UltrioPlex E Assay80134860306GRIFOLS BRASIL LTDAIV19/02/2034
ID RHD XT REAGENTES80134860307GRIFOLS BRASIL LTDAIV18/03/2034
Procleix ArboPlex Assay80134860311GRIFOLS BRASIL LTDAIV07/04/2035
Procleix ArboPlex Assay Calibrators80134860312GRIFOLS BRASIL LTDAIV07/04/2035
Discriminatory Probe Reagent (Procleix ArboPlex Assay)80134860313GRIFOLS BRASIL LTDAIV22/04/2035
Família Procleix UltrioPlex E Assay Calibrators80134860314GRIFOLS BRASIL LTDAIV23/06/2035
ID CORE CONTROL80134860315GRIFOLS BRASIL LTDAIV30/06/2035
Procleix Ultrio Elite Assay Calibrators80134860317GRIFOLS BRASIL LTDAIV07/07/2035
Target Enhancer Reagent Kit - Procleix Ultrio Elite Assay80134860319GRIFOLS BRASIL LTDAIV28/07/2035

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家